# ClinicalTrials.gov record NCT06751589

> PeptideScanner retained ClinicalTrials.gov record NCT06751589 at 2026-07-30T16:20:49.318Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06751589-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-04-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06751589-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06751589-tirzepatide-v1.json
- Content SHA-256: `b0ee69349b4b05a7a06d6ee48add3191f67b0ed519e03eb0625361629f4eb4aa`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06751589 ([`ctg-observation-nct06751589-2026-04-13-fb42de1bcb98`](#source-ctg-observation-nct06751589-2026-04-13-fb42de1bcb98))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06751589 at 2026-07-30T16:20:49.318Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06751589-2026-04-13-fb42de1bcb98`](#source-ctg-observation-nct06751589-2026-04-13-fb42de1bcb98))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06751589 at 2026-07-30T16:20:49.318Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06751589-2026-04-13-fb42de1bcb98`](#source-ctg-observation-nct06751589-2026-04-13-fb42de1bcb98))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06751589-2026-04-13-fb42de1bcb98`](#source-ctg-observation-nct06751589-2026-04-13-fb42de1bcb98))

## Sources

<a id="source-ctg-observation-nct06751589-2026-04-13-fb42de1bcb98"></a>
- **ClinicalTrials.gov record NCT06751589 · retained source version 2026-04-13:fb42de1bcb9836522dc655795b6833facb3779fa89c7433a4164d5952f8d99c1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06751589) (`ctg-observation-nct06751589-2026-04-13-fb42de1bcb98`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06751589." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06751589-tirzepatide-v1.json SHA-256: b0ee69349b4b05a7a06d6ee48add3191f67b0ed519e03eb0625361629f4eb4aa.